Enhanced efficacy with azacytidine and oncolytic BHV-1 in a tolerized cotton rat model of breast adenocarcinoma
Oncolytic viruses selectively replicate in cancer cells by exploiting biochemical differences between normal and tumor cells. Treatment with epigenetic modifiers such as 5-Azacytidine, a DNA methyltransferase inhibitor, increases the replication and cytotoxicity of oncolytic viruses in vivo and in v...
Main Authors: | Breanne P Cuddington, Meghan Verschoor, Ali Ashkar, Karen L Mossman |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2015-01-01
|
Series: | Molecular Therapy: Oncolytics |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2372770516300079 |
Similar Items
-
Oncolytic viruses: how “lytic” must they be for therapeutic efficacy?
by: Maria Eugenia Davola, et al.
Published: (2019-06-01) -
The Importance of Physiologically Relevant Cell Lines for Studying Virus–Host Interactions
by: David Hare, et al.
Published: (2016-11-01) -
Comparative pathogenicity of bovine herpesvirus 1 (BHV-1) subtypes 1 (BHV-1.1) and 2a (BHV-1.2a) Avaliação comparativa da patogenicidade de herpesvírus bovinos tipo 1 (BHV-1) subtipos 1 (BHV-1.1) e 2a (BHV-1.2a)
by: Fernando Rosado Spilki, et al.
Published: (2004-03-01) -
5-Azacytidine Potentiates Anti-tumor Immunity in a Model of Pancreatic Ductal Adenocarcinoma
by: Nancy D. Ebelt, et al.
Published: (2020-03-01) -
Anticorpos neutralizantes contra herpesvírus bovinos tipos 1 (BHV-1) e 5 (BHV-5) induzidos por uma vacina experimental anti-BHV-1 com adjuvante oleoso
by: Sylio Alfredo Petzhold, et al.
Published: (2001-01-01)